Naturally Splendid Responds to IIROC Request on Recent Trading Activity

Oct 2, 2018

Eastwood Bio-Medical Canada Publishes Corporate Presentation for Conference

Sep 26, 2018

Eastwood Bio-Medical Canada Announces Recent Progress of Eleotin® Products in Asia

Sep 24, 2018

Naturally Splendid Grants Stock Options

Sep 18, 2018

Naturally Splendid Cleared for Continued Trading On Frankfurt Exchange

Sep 13, 2018

Eastwood Bio-medical Canada Inc. Announces Product Approvals from the South Korean Government and Initial Shipment of Products to Korea

Sep 10, 2018

Naturally Splendid Provides Update On Clearstream Cannabis Related Securities List

Sep 5, 2018

Eastwood Bio-medical Canada Inc. Introduces New Cannabis and Cholesterol Products

Sep 5, 2018

Naturally Splendid Increases Vertical Integration and Expands International Footprint — CFN Media

Aug 27, 2018

Eastwood Bio-medical Canada Inc. Unaware of Any Material Change for Immediate Release

Aug 27, 2018

Naturally Splendid Reports Second Quarter Results for 2018

Aug 23, 2018

Naturally Splendid Secures Additional Purchase Order from Australian Distributor

Aug 20, 2018

Eastwood Bio-medical Canada Inc. Unaware of Any Material Change for Immediate Release

Aug 20, 2018

Naturally Splendid Comments on Health Canada’s Exemption to Industrial Hemp Regulations

Aug 17, 2018

Naturally Splendid Announces Purchase Order for National Distribution Bar Line

Aug 16, 2018

Naturally Splendid Closes Private Placement for $638,633.52

Aug 15, 2018

Naturally Splendid & CROP Enter Into Manufacturing and Supply Agreement for Hemp Products

Aug 14, 2018

Eastwood Bio-medical Canada Inc. Introduces New Product For Memory and Cognitive Function in Adults

Aug 9, 2018